Gas6 Expression in Breast Cancer
Author Information
Author(s): Mc Cormack O, Chung W Y, Fitzpatrick P, Cooke F, Flynn B, Harrison M, Fox E, Gallagher E, Goldrick A Mc, Dervan P A, Mc Cann A, Kerin M J
Primary Institution: UCD School of Medicine and Medical Science, UCD Conway Institute, Belfield, Dublin 4, Ireland
Hypothesis
The study aims to validate the expression of Gas6 in primary breast carcinomas and evaluate its clinical relevance in breast carcinogenesis.
Conclusion
The study confirms a positive association between PRB protein and Gas6 mRNA levels in breast cancer tissue, indicating that Gas6 may be linked to favorable prognostic factors.
Supporting Evidence
- Gas6 expression was positively associated with PRB protein levels.
- Higher Gas6 levels were found in younger women with breast cancer.
- Gas6 levels correlated inversely with tumor size and lymph node metastases.
Takeaway
This study found that a protein called Gas6 is linked to better outcomes in breast cancer, especially in younger women and those with smaller tumors.
Methodology
Quantitative real-time PCR was used to measure Gas6 mRNA levels in breast cancer tissues, and PRB protein was evaluated using immunohistochemistry.
Limitations
Gas6 mRNA levels were not independently associated with disease-free interval or overall survival in this cohort.
Participant Demographics
The mean age of participants was 60 years, with a range from 33 to 87 years.
Statistical Information
P-Value
P=0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website